NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th – NV-387 is Effective Against H3N2

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

BioCytics Successfully Completes a Key Regulatory Milestone with Recent FDA INTERACT Meeting

BioCytics is pleased to announce they successfully reached a regulatory milestone for de-risking clinical development plans with a productive FDA INTERACT meeting during which they discussed ...

A new gateway to global antimicrobial resistance data

Antimicrobial resistance (AMR) is a growing health challenge, reducing the effectiveness of life-saving treatments and ...
BMJ Global Health

Improving Sierra Leone’s skilled health-worker-to-population ratio: how unsalaried and auxiliary health workers are barriers in its path to universal health coverage

Background Achieving Universal Health Coverage (UHC) is one of Sierra Leone’s main health policy goals. To achieve UHC, a ...
MedTech Intelligence

Navigating U.S.-EU Medical Device Regulation: Innovative Strategies for Global Compliance

The medical device industry faces growing pressure to align U.S. and EU regulations, with the EU’s Medical Device Regulation ...